[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340108-105":59,"doc-detail-340108-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identifications-of-similarity-metrics-for-patients-with-cancer-protocol-for-a-scoping-review","Identifications of Similarity Metrics for Patients With Cancer - Protocol for a Scoping Review","","Understanding patient similarity in cancer is crucial for advancing personalized medicine, improving outcomes, and enabling more effective, individualized treatments. It supports researchers in identifying patterns, biomarkers, and treatment strategies and helps clinicians decide treatments for patients who are clinically or molecularly similar. The review systematically maps and describes existing evidence on how patient similarity is defined and applied in cancer research and clinical care.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identifications-of-similarity-metrics-for-patients-with-cancer-protocol-for-a-scoping-review/340108/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identifications-of-similarity-metrics-for-patients-with-cancer-protocol-for-a-scoping-review/340108.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this scoping review protocol?","Question",{"text":112,"@type":113},"The protocol aims to systematically summarize, map, and describe existing evidence on how patient similarity is defined and used in cancer research and clinical care.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases and time range will be searched?",{"text":117,"@type":113},"The literature search will cover several bibliographic databases, including Web of Science, PubMed, LIVIVIVO, and MEDLINE, from 1998 to February 2024.",{"name":119,"@type":110,"acceptedAnswer":120},"How will studies be selected and screened?",{"text":121,"@type":113},"After initial duplicate deletion, selection will use Rayyan with three steps: title and abstract screening, disagreement resolution, and full-text screening, preceded by pilot testing for each step.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340108,1790837754,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","JMIR RESEARCH PROTOCOLS Manuilova et al  \nProtocol  \nIdentifications of Similarity Metrics for Patients With Cancer: Protocol for a Scoping Review  \nIryna Manuilova 1,2, MS; Jan Bossenz 1 ; Annemarie Bianka Weise 1 ; Dominik Boehm3,4, MS; Cosima Strantz5, MS; Philipp Unberath3,6, Prof Dr; Niklas Reimer7,8,9, MS; Patrick Metzger10,11, Dr rer nat; Thomas Pauli 10, Dr rer nat; Silke D Werle 12, Dr rer nat; Susann Schulze13, Dr med; Sonja Hiemer13, Dr med; Arsenij Ustjanzew14, MS; Hans A Kestler12, Prof Dr; Hauke Busch7,8, Prof Dr; Benedikt Brors15,16,17,18, Prof Dr; Jan Christoph1,2,5, Jr Prof Dr  \n1Junior Research Group (Bio-) Medical Data Science, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany 2Data Integration Centre, University Hospital Halle (Saale), Halle (Saale), Germany  \n3Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany  \n4Bavarian Cancer Research Center (Bayerisches Zentrum für Krebsforschung), Erlangen, Germany  \n5Medical Informatics, Institute for Medical Informatics, Biometrics and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany  \n6SRH Fürth University of Applied Sciences, Fürth, Germany  \n7Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany 8University Cancer Center Schleswig-Holstein, University Hospital Schleswig-Holstein, Lübeck, Germany  \n9Medical Data Integration Center, University Hospital Schleswig-Holstein, Lübeck, Germany  \n10Institute of Medical Bioinformatics and Systems Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany 11Clinical Trial Office, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany  \n12Institute of Medical Systems Biology, Ulm University, Ulm, Germany 13Krukenberg Cancer Center Halle (Saale), Halle (Saale), Germany  \n14Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany  \n15Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany 16German Cancer Consortium, Heidelberg, Germany  \n17National Center for Tumor Diseases (NCT), Heidelberg, Germany  \n18Medical Faculty Heidelberg and Faculty of Biosciences, Heidelberg University, Heidelberg, Germany  \nCorresponding Author:  \nIryna Manuilova, MS  \nJunior Research Group (Bio-) Medical Data Science Faculty of Medicine  \nMartin Luther University Halle-Wittenberg Magdeburger Str 8  \nHalle (Saale), 06112 Germany  \nPhone: 49 345 557 2651  \nEmail: [Iryna.Manuilova@uk-halle.de](Iryna.Manuilova@uk-halle.de)  \nAbstract  \nBackground: Understanding the similarities of patients with cancer is essential to advancing personalized medicine, improving patient outcomes, and developing more effective and individualized treatments. It enables researchers to discover important patterns, biomarkers, and treatment strategies that can have a significant impact on cancer research and oncology. In addition, the identification ofpreviously successfully treated patients supports oncologists in making treatment decisions for a new patient who is clinically or molecularly similar to the previous patient.  \nObjective: The planned review aims to systematically summarize, map, and describe existing evidence to understand how patient similarity is defined and used in cancer research and clinical care.  \n[https://www.researchprotocols.org/2024/1/e58705](https://www.researchprotocols.org/2024/1/e58705)  \nXSL• FO  \nRenderX  \nJMIR Res Protoc 2024 | vol. 13 | e58705 | p. 1 (page number not for citation purposes)  \nMethods: To systematically identify relevant studies and to ensure reproducibility and transparency of the review process, a comprehensive literature search will be conducted in several bibliographic databases, including Web of Science, ","cbCaib7ljEMFPii9","https://ap.wps.com/l/cbCaib7ljEMFPii9","pdf",151649,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Background\n# Key terms","[{\"question\":\"What is the main purpose of this scoping review protocol?\",\"answer\":\"The protocol aims to systematically summarize, map, and describe existing evidence on how patient similarity is defined and used in cancer research and clinical care.\"},{\"question\":\"Which databases and time range will be searched?\",\"answer\":\"The literature search will cover several bibliographic databases, including Web of Science, PubMed, LIVIVIVO, and MEDLINE, from 1998 to February 2024.\"},{\"question\":\"How will studies be selected and screened?\",\"answer\":\"After initial duplicate deletion, selection will use Rayyan with three steps: title and abstract screening, disagreement resolution, and full-text screening, preceded by pilot testing for each step.\"}]","Identifications of Similarity Metrics for Patients With Cancer - Protocol for a Scoping Review | PDF",1790034209,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c855de40a454431fdb2de64aa79d03d2.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04032df6f06e8bb76a48dde0e72aa38b.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db54685e63f3c633f50299d33f8eebd1.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34754a6941a26b39ca0c98a30caae3e3.webp",980,1385]